Coalition of cancer groups urges Congress to include clinical trial-related coverage under Medicaid February 21, 2020Vol.46 No.08By Alexandria Carolan
25 years ago: Here is The Cancer Letter’s coverage of Michael Milken’s 1995 cancer summit February 21, 2020Vol.46 No.08By Paul Goldberg
Trump grants clemency to Michael Milken, financier whose ideas brought new money & swagger into cancer politics, research February 21, 2020Vol.46 No.08By Paul Goldberg
FreeGuest Editorial Lung-MAP: A five-year recap on the first master protocol trial in cancer research February 21, 2020Vol.46 No.08By Roy S. Herbst, Lyudmila Bazhenova, Joel Neal and Saiama N. Waqar
Ohio State expands assistance program to give out previously dispensed cancer drugs February 14, 2020Vol.46 No.07By Alexandria Carolan
NCI Sharpless addresses three big issues in cancer in 2020:1. NCI grantees are prime targets for foreign influence, 2. Treatment seems to drive drop in lung cancer deaths, 3. RPG paylines to rise from 8% to 10% February 14, 2020Vol.46 No.07By Matthew Bin Han Ong
American Cancer Society CEO Gary Reedy cedes day-to-day operations to chief operating officer February 07, 2020Vol.46 No.06By Paul Goldberg
Conversation with The Cancer Letter NCI’s Penberthy: We may be seeing some impact of treatment in lung cancer mortality, but we need more data February 07, 2020Vol.46 No.06By Matthew Bin Han Ong
